English
简体中文
Total: £ 56.28
Published Date: 2026-03-12 | Pages: 119 | Tables: 119 | Pharma & Healthcare
The global Oral Anorexiant Drug market was valued at US$ 826 million in 2025 and is anticipated to reach US$ 1235 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oral Anorexiant Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Oral anorexiant drugs are medications designed to suppress appetite and reduce food intake, aiding in weight loss for individuals who are overweight or obese. These drugs typically act on the central nervous system, either by stimulating the release of certain neurotransmitters like norepinephrine and dopamine, which can create a feeling of fullness, or by blocking the reuptake of these chemicals, prolonging their appetite-suppressing effects. Commonly prescribed oral anorexiants include phentermine, diethylpropion, and lorcaserin. They are often used in conjunction with lifestyle modifications such as diet and exercise to enhance weight loss results. However, these medications can have side effects such as increased heart rate, elevated blood pressure, insomnia, and potential for abuse or dependency, and they are usually recommended for short-term use under medical supervision.
The North American market for Oral Anorexiant Drug is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Oral Anorexiant Drug is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Oral Anorexiant Drug include Akrimax Pharmaceuticals, Janssen Ortho, Roche Pharmaceuticals, Teva Pharmaceuticals, Arena Pharmaceuticals, Abbott Pharmaceuticals, Epic Pharma, Novo Nordisk, Patheon Pharmaceuticals, Recordati Rare Diseases, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Oral Anorexiant Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oral Anorexiant Drug. The Oral Anorexiant Drug market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Oral Anorexiant Drug market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oral Anorexiant Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Akrimax Pharmaceuticals
Janssen Ortho
Roche Pharmaceuticals
Teva Pharmaceuticals
Arena Pharmaceuticals
Abbott Pharmaceuticals
Epic Pharma
Novo Nordisk
Patheon Pharmaceuticals
Recordati Rare Diseases
Catalent Pharma Solutions
MOVA Pharmaceuticals
Segment by Type
Catecholamines
Serotonin
by Application
Hospitals
Clinics
Retail Sales
Online Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Oral Anorexiant Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Oral Anorexiant Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Oral Anorexiant Drug Market Overview
1.1 Product Definition
1.2 Oral Anorexiant Drug by Type
1.2.1 Global Oral Anorexiant Drug Market Value by Type: 2025 vs 2032
1.2.2 Catecholamines
1.2.3 Serotonin
1.3 Oral Anorexiant Drug by Application
1.3.1 Global Oral Anorexiant Drug Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Sales
1.3.5 Online Pharmacies
1.3.6 Other
1.4 Global Oral Anorexiant Drug Market Size Estimates and Forecasts
1.4.1 Global Oral Anorexiant Drug Revenue 2021–2032
1.4.2 Global Oral Anorexiant Drug Sales 2021–2032
1.4.3 Global Oral Anorexiant Drug Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Oral Anorexiant Drug Market Competition by Manufacturers
2.1 Global Oral Anorexiant Drug Sales Market Share by Manufacturers (2021–2026)
2.2 Global Oral Anorexiant Drug Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Oral Anorexiant Drug Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Oral Anorexiant Drug, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Oral Anorexiant Drug, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Oral Anorexiant Drug, Product Types and Applications
2.7 Global Key Manufacturers of Oral Anorexiant Drug, Date of Entry into the Industry
2.8 Global Oral Anorexiant Drug Market Competitive Situation and Trends
2.8.1 Global Oral Anorexiant Drug Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Oral Anorexiant Drug Players Market Share by Revenue
2.8.3 Global Oral Anorexiant Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Anorexiant Drug Market Scenario by Region
3.1 Global Oral Anorexiant Drug Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Oral Anorexiant Drug Sales by Region: 2021–2032
3.2.1 Global Oral Anorexiant Drug Sales by Region: 2021–2026
3.2.2 Global Oral Anorexiant Drug Sales by Region: 2027–2032
3.3 Global Oral Anorexiant Drug Revenue by Region: 2021–2032
3.3.1 Global Oral Anorexiant Drug Revenue by Region: 2021–2026
3.3.2 Global Oral Anorexiant Drug Revenue by Region: 2027–2032
3.4 North America Oral Anorexiant Drug Market Facts & Figures by Country
3.4.1 North America Oral Anorexiant Drug Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Oral Anorexiant Drug Sales by Country (2021–2032)
3.4.3 North America Oral Anorexiant Drug Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Anorexiant Drug Market Facts & Figures by Country
3.5.1 Europe Oral Anorexiant Drug Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Oral Anorexiant Drug Sales by Country (2021–2032)
3.5.3 Europe Oral Anorexiant Drug Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Anorexiant Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Anorexiant Drug Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Oral Anorexiant Drug Sales by Region (2021–2032)
3.6.3 Asia Pacific Oral Anorexiant Drug Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Anorexiant Drug Market Facts & Figures by Country
3.7.1 Latin America Oral Anorexiant Drug Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Oral Anorexiant Drug Sales by Country (2021–2032)
3.7.3 Latin America Oral Anorexiant Drug Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Anorexiant Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Anorexiant Drug Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Oral Anorexiant Drug Sales by Country (2021–2032)
3.8.3 Middle East and Africa Oral Anorexiant Drug Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Anorexiant Drug Sales by Type (2021–2032)
4.1.1 Global Oral Anorexiant Drug Sales by Type (2021–2026)
4.1.2 Global Oral Anorexiant Drug Sales by Type (2027–2032)
4.1.3 Global Oral Anorexiant Drug Sales Market Share by Type (2021–2032)
4.2 Global Oral Anorexiant Drug Revenue by Type (2021–2032)
4.2.1 Global Oral Anorexiant Drug Revenue by Type (2021–2026)
4.2.2 Global Oral Anorexiant Drug Revenue by Type (2027–2032)
4.2.3 Global Oral Anorexiant Drug Revenue Market Share by Type (2021–2032)
4.3 Global Oral Anorexiant Drug Price by Type (2021–2032)
5 Segment by Application
5.1 Global Oral Anorexiant Drug Sales by Application (2021–2032)
5.1.1 Global Oral Anorexiant Drug Sales by Application (2021–2026)
5.1.2 Global Oral Anorexiant Drug Sales by Application (2027–2032)
5.1.3 Global Oral Anorexiant Drug Sales Market Share by Application (2021–2032)
5.2 Global Oral Anorexiant Drug Revenue by Application (2021–2032)
5.2.1 Global Oral Anorexiant Drug Revenue by Application (2021–2026)
5.2.2 Global Oral Anorexiant Drug Revenue by Application (2027–2032)
5.2.3 Global Oral Anorexiant Drug Revenue Market Share by Application (2021–2032)
5.3 Global Oral Anorexiant Drug Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Akrimax Pharmaceuticals
6.1.1 Akrimax Pharmaceuticals Company Information
6.1.2 Akrimax Pharmaceuticals Description and Business Overview
6.1.3 Akrimax Pharmaceuticals Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Akrimax Pharmaceuticals Oral Anorexiant Drug Product Portfolio
6.1.5 Akrimax Pharmaceuticals Recent Developments/Updates
6.2 Janssen Ortho
6.2.1 Janssen Ortho Company Information
6.2.2 Janssen Ortho Description and Business Overview
6.2.3 Janssen Ortho Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Janssen Ortho Oral Anorexiant Drug Product Portfolio
6.2.5 Janssen Ortho Recent Developments/Updates
6.3 Roche Pharmaceuticals
6.3.1 Roche Pharmaceuticals Company Information
6.3.2 Roche Pharmaceuticals Description and Business Overview
6.3.3 Roche Pharmaceuticals Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Roche Pharmaceuticals Oral Anorexiant Drug Product Portfolio
6.3.5 Roche Pharmaceuticals Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceuticals Oral Anorexiant Drug Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Arena Pharmaceuticals
6.5.1 Arena Pharmaceuticals Company Information
6.5.2 Arena Pharmaceuticals Description and Business Overview
6.5.3 Arena Pharmaceuticals Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Arena Pharmaceuticals Oral Anorexiant Drug Product Portfolio
6.5.5 Arena Pharmaceuticals Recent Developments/Updates
6.6 Abbott Pharmaceuticals
6.6.1 Abbott Pharmaceuticals Company Information
6.6.2 Abbott Pharmaceuticals Description and Business Overview
6.6.3 Abbott Pharmaceuticals Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Abbott Pharmaceuticals Oral Anorexiant Drug Product Portfolio
6.6.5 Abbott Pharmaceuticals Recent Developments/Updates
6.7 Epic Pharma
6.7.1 Epic Pharma Company Information
6.7.2 Epic Pharma Description and Business Overview
6.7.3 Epic Pharma Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Epic Pharma Oral Anorexiant Drug Product Portfolio
6.7.5 Epic Pharma Recent Developments/Updates
6.8 Novo Nordisk
6.8.1 Novo Nordisk Company Information
6.8.2 Novo Nordisk Description and Business Overview
6.8.3 Novo Nordisk Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Novo Nordisk Oral Anorexiant Drug Product Portfolio
6.8.5 Novo Nordisk Recent Developments/Updates
6.9 Patheon Pharmaceuticals
6.9.1 Patheon Pharmaceuticals Company Information
6.9.2 Patheon Pharmaceuticals Description and Business Overview
6.9.3 Patheon Pharmaceuticals Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Patheon Pharmaceuticals Oral Anorexiant Drug Product Portfolio
6.9.5 Patheon Pharmaceuticals Recent Developments/Updates
6.10 Recordati Rare Diseases
6.10.1 Recordati Rare Diseases Company Information
6.10.2 Recordati Rare Diseases Description and Business Overview
6.10.3 Recordati Rare Diseases Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Recordati Rare Diseases Oral Anorexiant Drug Product Portfolio
6.10.5 Recordati Rare Diseases Recent Developments/Updates
6.11 Catalent Pharma Solutions
6.11.1 Catalent Pharma Solutions Company Information
6.11.2 Catalent Pharma Solutions Description and Business Overview
6.11.3 Catalent Pharma Solutions Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Catalent Pharma Solutions Oral Anorexiant Drug Product Portfolio
6.11.5 Catalent Pharma Solutions Recent Developments/Updates
6.12 MOVA Pharmaceuticals
6.12.1 MOVA Pharmaceuticals Company Information
6.12.2 MOVA Pharmaceuticals Description and Business Overview
6.12.3 MOVA Pharmaceuticals Oral Anorexiant Drug Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 MOVA Pharmaceuticals Oral Anorexiant Drug Product Portfolio
6.12.5 MOVA Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Anorexiant Drug Industry Chain Analysis
7.2 Oral Anorexiant Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Anorexiant Drug Production Mode & Process Analysis
7.4 Oral Anorexiant Drug Sales and Marketing
7.4.1 Oral Anorexiant Drug Sales Channels
7.4.2 Oral Anorexiant Drug Distributors
7.5 Oral Anorexiant Drug Customer Analysis
8 Oral Anorexiant Drug Market Dynamics
8.1 Oral Anorexiant Drug Industry Trends
8.2 Oral Anorexiant Drug Market Drivers
8.3 Oral Anorexiant Drug Market Challenges
8.4 Oral Anorexiant Drug Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Oral Anorexiant Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Anorexiant Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Oral Anorexiant Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Oral Anorexiant Drug Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Oral Anorexiant Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Oral Anorexiant Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Oral Anorexiant Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Oral Anorexiant Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Oral Anorexiant Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Oral Anorexiant Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Oral Anorexiant Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Oral Anorexiant Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Anorexiant Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Anorexiant Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Anorexiant Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Oral Anorexiant Drug Sales by Region (K Units), 2021–2026
Table 18. Global Oral Anorexiant Drug Sales Market Share by Region (2021–2026)
Table 19. Global Oral Anorexiant Drug Sales by Region (K Units), 2027–2032
Table 20. Global Oral Anorexiant Drug Sales Market Share by Region (2027–2032)
Table 21. Global Oral Anorexiant Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Oral Anorexiant Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Oral Anorexiant Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Oral Anorexiant Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Oral Anorexiant Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Oral Anorexiant Drug Sales by Country (K Units), 2021–2026
Table 27. North America Oral Anorexiant Drug Sales by Country (K Units), 2027–2032
Table 28. North America Oral Anorexiant Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Oral Anorexiant Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Oral Anorexiant Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Oral Anorexiant Drug Sales by Country (K Units), 2021–2026
Table 32. Europe Oral Anorexiant Drug Sales by Country (K Units), 2027–2032
Table 33. Europe Oral Anorexiant Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Oral Anorexiant Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Oral Anorexiant Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Oral Anorexiant Drug Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Oral Anorexiant Drug Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Oral Anorexiant Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Oral Anorexiant Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Oral Anorexiant Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Oral Anorexiant Drug Sales by Country (K Units), 2021–2026
Table 42. Latin America Oral Anorexiant Drug Sales by Country (K Units), 2027–2032
Table 43. Latin America Oral Anorexiant Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Oral Anorexiant Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Oral Anorexiant Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Oral Anorexiant Drug Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Oral Anorexiant Drug Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Oral Anorexiant Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Oral Anorexiant Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Oral Anorexiant Drug Sales (K Units) by Type (2021–2026)
Table 51. Global Oral Anorexiant Drug Sales (K Units) by Type (2027–2032)
Table 52. Global Oral Anorexiant Drug Sales Market Share by Type (2021–2026)
Table 53. Global Oral Anorexiant Drug Sales Market Share by Type (2027–2032)
Table 54. Global Oral Anorexiant Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Oral Anorexiant Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Oral Anorexiant Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Oral Anorexiant Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Oral Anorexiant Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Oral Anorexiant Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Oral Anorexiant Drug Sales (K Units) by Application (2021–2026)
Table 61. Global Oral Anorexiant Drug Sales (K Units) by Application (2027–2032)
Table 62. Global Oral Anorexiant Drug Sales Market Share by Application (2021–2026)
Table 63. Global Oral Anorexiant Drug Sales Market Share by Application (2027–2032)
Table 64. Global Oral Anorexiant Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Oral Anorexiant Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Oral Anorexiant Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Oral Anorexiant Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Oral Anorexiant Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Oral Anorexiant Drug Price (US$/Unit) by Application (2027–2032)
Table 70. Akrimax Pharmaceuticals Company Information
Table 71. Akrimax Pharmaceuticals Description and Business Overview
Table 72. Akrimax Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Akrimax Pharmaceuticals Oral Anorexiant Drug Product
Table 74. Akrimax Pharmaceuticals Recent Developments/Updates
Table 75. Janssen Ortho Company Information
Table 76. Janssen Ortho Description and Business Overview
Table 77. Janssen Ortho Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Janssen Ortho Oral Anorexiant Drug Product
Table 79. Janssen Ortho Recent Developments/Updates
Table 80. Roche Pharmaceuticals Company Information
Table 81. Roche Pharmaceuticals Description and Business Overview
Table 82. Roche Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Roche Pharmaceuticals Oral Anorexiant Drug Product
Table 84. Roche Pharmaceuticals Recent Developments/Updates
Table 85. Teva Pharmaceuticals Company Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Teva Pharmaceuticals Oral Anorexiant Drug Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Arena Pharmaceuticals Company Information
Table 91. Arena Pharmaceuticals Description and Business Overview
Table 92. Arena Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Arena Pharmaceuticals Oral Anorexiant Drug Product
Table 94. Arena Pharmaceuticals Recent Developments/Updates
Table 95. Abbott Pharmaceuticals Company Information
Table 96. Abbott Pharmaceuticals Description and Business Overview
Table 97. Abbott Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Abbott Pharmaceuticals Oral Anorexiant Drug Product
Table 99. Abbott Pharmaceuticals Recent Developments/Updates
Table 100. Epic Pharma Company Information
Table 101. Epic Pharma Description and Business Overview
Table 102. Epic Pharma Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Epic Pharma Oral Anorexiant Drug Product
Table 104. Epic Pharma Recent Developments/Updates
Table 105. Novo Nordisk Company Information
Table 106. Novo Nordisk Description and Business Overview
Table 107. Novo Nordisk Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Novo Nordisk Oral Anorexiant Drug Product
Table 109. Novo Nordisk Recent Developments/Updates
Table 110. Patheon Pharmaceuticals Company Information
Table 111. Patheon Pharmaceuticals Description and Business Overview
Table 112. Patheon Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Patheon Pharmaceuticals Oral Anorexiant Drug Product
Table 114. Patheon Pharmaceuticals Recent Developments/Updates
Table 115. Recordati Rare Diseases Company Information
Table 116. Recordati Rare Diseases Description and Business Overview
Table 117. Recordati Rare Diseases Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Recordati Rare Diseases Oral Anorexiant Drug Product
Table 119. Recordati Rare Diseases Recent Developments/Updates
Table 120. Catalent Pharma Solutions Company Information
Table 121. Catalent Pharma Solutions Description and Business Overview
Table 122. Catalent Pharma Solutions Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Catalent Pharma Solutions Oral Anorexiant Drug Product
Table 124. Catalent Pharma Solutions Recent Developments/Updates
Table 125. MOVA Pharmaceuticals Company Information
Table 126. MOVA Pharmaceuticals Description and Business Overview
Table 127. MOVA Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. MOVA Pharmaceuticals Oral Anorexiant Drug Product
Table 129. MOVA Pharmaceuticals Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Oral Anorexiant Drug Distributors List
Table 133. Oral Anorexiant Drug Customers List
Table 134. Oral Anorexiant Drug Market Trends
Table 135. Oral Anorexiant Drug Market Drivers
Table 136. Oral Anorexiant Drug Market Challenges
Table 137. Oral Anorexiant Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Anorexiant Drug
Figure 2. Global Oral Anorexiant Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Anorexiant Drug Market Share by Type: 2025 & 2032
Figure 4. Catecholamines Product Picture
Figure 5. Serotonin Product Picture
Figure 6. Global Oral Anorexiant Drug Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Oral Anorexiant Drug Market Share by Application: 2025 & 2032
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Retail Sales
Figure 11. Online Pharmacies
Figure 12. Other
Figure 13. Global Oral Anorexiant Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Oral Anorexiant Drug Market Size (US$ Million), 2021–2032
Figure 15. Global Oral Anorexiant Drug Sales (K Units), 2021–2032
Figure 16. Global Oral Anorexiant Drug Average Price (US$/Unit), 2021–2032
Figure 17. Oral Anorexiant Drug Report Years Considered
Figure 18. Oral Anorexiant Drug Sales Share by Manufacturers in 2025
Figure 19. Global Oral Anorexiant Drug Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Oral Anorexiant Drug Players: Market Share by Revenue in Oral Anorexiant Drug in 2025
Figure 21. Oral Anorexiant Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Oral Anorexiant Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Oral Anorexiant Drug Sales Market Share by Country (2021–2032)
Figure 24. North America Oral Anorexiant Drug Revenue Market Share by Country (2021–2032)
Figure 25. United States Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Oral Anorexiant Drug Sales Market Share by Country (2021–2032)
Figure 28. Europe Oral Anorexiant Drug Revenue Market Share by Country (2021–2032)
Figure 29. Germany Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Oral Anorexiant Drug Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Oral Anorexiant Drug Revenue Market Share by Region (2021–2032)
Figure 36. China Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Oral Anorexiant Drug Sales Market Share by Country (2021–2032)
Figure 44. Latin America Oral Anorexiant Drug Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Oral Anorexiant Drug Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Oral Anorexiant Drug Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Oral Anorexiant Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Oral Anorexiant Drug by Type (2021–2032)
Figure 55. Global Revenue Market Share of Oral Anorexiant Drug by Type (2021–2032)
Figure 56. Global Oral Anorexiant Drug Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Oral Anorexiant Drug by Application (2021–2032)
Figure 58. Global Revenue Market Share of Oral Anorexiant Drug by Application (2021–2032)
Figure 59. Global Oral Anorexiant Drug Price (US$/Unit) by Application (2021–2032)
Figure 60. Oral Anorexiant Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
